Details of the Drug Reposition

General Information of This Drug (ID: DMZXDBN)

Drug Name
HER2-CAR T Cells   DMZXDBN
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Malignant neoplasm DISS6SNG 2A00-2F9Z Phase 1 [1]
Metastatic malignant neoplasm DIS86UK6 2D50-2E09 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03696030) HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases